News

New antivirals, more screening could slash hepatitis C cases


 

FROM CLINICAL INFECTIOUS DISEASES

References

Pages

Recommended Reading

Transplant waiting-list registrations dropped after direct acting–antiviral approval
MDedge Infectious Disease
Investigational hepatitis B therapy shows activity in proof-of-concept study
MDedge Infectious Disease
Elevated liver cancer risk after HCV cure may justify surveillance
MDedge Infectious Disease
AASLD: Pilot study shows value of response-guided therapy for HCV GT1b
MDedge Infectious Disease
AASLD: HCV cure associated with reduction in all-cause mortality
MDedge Infectious Disease
VIDEO: U.S. hepatitis C treatment capacity falls short of need
MDedge Infectious Disease
Short-course DAA regimens for HCV provide limited cure rates
MDedge Infectious Disease
ARC-520 shows promise in chronic hepatitis B
MDedge Infectious Disease
Proportion of HCV patients in U.S. with cirrhosis climbing
MDedge Infectious Disease
ELF the most effective mortality predictor for coinfected HIV, HCV patients
MDedge Infectious Disease